B

Braveheart Bio Inc.
D

BRVE

28.905
USD
-0.28
(-0.94%)
مفتوح الان
حجم التداول
112
الربح لكل سهم
0
العائد الربحي
-
P/E
-18
حجم السوق
2,602,576,399
المقالات
المزيد

العنوان: Braveheart Bio Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).